VYGR Operating Income Growth
Voyager Therapeutics Inc · Operating Income Growth
VYGR Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported5.03%period ending
VYGR TTM Operating Income YoY % (-40.98% → 5.03%)
Year-over-year change
High-resolution chart · PNG
VYGR operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 5.0317% | |
| -25.1717% | |
| -58.3008% | |
| -1,645.0248% | |
| -1,755.0361% | |
| -496.9448% | |
| -168.2602% | |
| -79.0841% | |
| -107.6165% | |
| -118.2588% | |
| 340.0055% | |
| 310.8978% | |
| 245.1721% | |
| 234.6171% | |
| 30.9435% | |
| 80.0357% | |
| -1,008.2277% | |
| -364.5226% | |
| -368.8358% | |
| -375.9379% | |
| 110.1925% | |
| 156.02% | |
| 152.9886% | |
| 161.1491% | |
| -0.8958% | |
| 52.8486% | |
| 43.2691% | |
| 23.9282% | |
| 21.9154% | |
| -31.6299% | |
| -26.7603% | |
| -9.4386% | |
| -36.6317% | |
| -46.895% | |
| -74.0133% | |
| -110.2189% | |
| -111.5121% | |
| -124.3175% | |
| -103.9005% | |
| -101.5945% | |
| -68.431% | |
| -41.2276% | |
| -40.9758% |